NCT05106140 Robotic Evaluations of Motor Learning During Stroke Neurorehabilitation
| NCT ID | NCT05106140 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Calgary |
| Condition | Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2021-09-20 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2021-09-20 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The RELEARN trial is a a prospective longitudinal cohort study sampled by convenience. Stroke survivors and healthy control individuals will be recruited to analyze motor learning in the upper extremity and its neural basis in early stroke recovery.
Eligibility Criteria
Inclusion Criteria for Stroke Participants: * First time, unilateral ischemic stroke in middle cerebral artery territory, motor and/or sensory tracts and confirmed by clinical examination (including neuroimaging) * 7±6 days post-stroke * Upper limb impairment * \>18 years old * Fugl-Meyer upper extremity score between 30 and 57 * Vision better than 20/50 (corrected) * Able to follow 3-step task commands Inclusion Criteria for Control Participants: * \>18 years old * Good health Exclusion Criteria for Stroke Participants: * History of: 1. past undiagnosed stroke (evident on neuroimaging), 2. neglect (screened with Behavioral Inattention Test), 3. apraxia, or 4. upper extremity orthopedic or muscular issues * Secondary neurologic injury or disease (e.g., Parkinson's) * Contraindication to MRI * Medical or neuropsychiatric conditions that would interfere with study outcomes, or where participation presents a risk to the subject * Enrollment in an interventional trial that supplements standard therapy Exclusion Criteria for Control Participants: • Significant upper limb neurologic or orthopedic conditions
Contact & Investigator
Tyler Cluff, PhD
PRINCIPAL INVESTIGATOR
University of Calgary
Frequently Asked Questions
Who can join the NCT05106140 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05106140 currently recruiting?
Yes, NCT05106140 is actively recruiting participants. Contact the research team at rnstone@ucalgary.ca for enrollment information.
Where is the NCT05106140 trial being conducted?
This trial is being conducted at Calgary, Canada, Calgary, Canada, Calgary, Canada, Calgary, Canada.
Who is sponsoring the NCT05106140 clinical trial?
NCT05106140 is sponsored by University of Calgary. The principal investigator is Tyler Cluff, PhD at University of Calgary. The trial plans to enroll 300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.